Categories: FinTechHardwareHealthTechMarketMedTechProduct
Venus Medtech focuses on the R&D of transvascular intervention device
Investors 4
Funding Rounds 1
Mentions in press and media 8
| Date | Title | Description | Source |
| 05.02.2024 | Venus Medtech VenusP-Valve transcatheter pulmonic valve repl... | HANGZHOU, China, Feb. 5, 2024 /PRNewswire/ -- Venus Medtech (02500. HK), a leading provider of integ... | en.prnasia... |
| 18.05.2018 | Venus Medtech Receives Equity Investment from DCP Capital | Venus Medtech, a Hangzhou, China-based heart valve technology developer, received an investment from... | finsmes.co... |
| 16.05.2018 | Term Sheet — Wednesday, May 16 | CRYPTO UNICORN
Good morning, Term Sheet readers.
Paid Content You can't secure what you can't see Fr... | fortune.co... |
| 28.03.2016 | Daily funding roundup - March 28, 2016 | Emulate secured $28M; Goldman Sachs invested in Venus Medtech; Fixt received $600k Seed funding
Flyr... | vator.tv/n... |
| 28.03.2016 | Venus Medtech Receives $37M Investment from Goldman Sachs | Venus Medtech (Hangzhou) Inc., a Hangzhou, China-based transcatheter cardiac valve developer, receiv... | finsmes.co... |
| 25.03.2016 | Goldman Sachs throws in $37M with Chinese replacement heart ... | The A-Valve is the only TAVR device that meets China Food & Drug Administration requirements. Th... | medcitynew... |
| - | Goldman Sachs throws in $37M with Chinese replacement heart ... | Chinese replacement heart valve maker Venus Medtech has announced that it received a $37 million inv... | medcitynew... |
| - | Venus Medtech and Opus Medical Therapies, LLC Announce Partn... | NEWS PROVIDED BY | tidewateri... |
Reviews 0
